A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Clinical trial NCT06963827 · RECRUITING
Trial details
- NCT number
- NCT06963827
- Sponsor
- Takeda
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2028-09-07
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.